Navigation Links
Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
Date:8/21/2008

ted with treatment resistance; OGX-427 and SN2310 are in Phase 1 clinical development; and CSP-9222 and OGX-225 are currently in pre-clinical development. More information is available at http://www.oncogenex.com.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements concerning the Company's common stock listing, restructuring, anticipated clinical and preclinical activities and product potential. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. For example, statements of expected synergies, the strength of the combined oncology product pipeline, the timing of clinical trials and development efforts, the results of clinical and pre-clinical studies, the timing of closing, execution of integration plans and management and organizational structure are all forward-looking statements. The potential risks and uncertainties include, among others, the possibility that costs savings will not be achieved or that the Company is unable to successfully execute its integration strategy, the timing and costs of clinical trials and regulatory approvals, risks that clinical trials will not be successful, risks associated with obtaining funding from third parties or completing a financing necessary to support the costs and expenses of clinical studies as well as research and development activities, risks that the combined company will not be able to maintain listing on NASDAQ, as well as other risks relating to the development, safety and efficacy of therapeutic drugs and potent
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
2. Sonus Pharmaceuticals Receives Favorable NASDAQ Decision
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 Research ... "Global and China Gel Permeation Chromatography (GPC) Industry ... The Global and China Gel Permeation Chromatography (GPC) ... the current state of the global gel permeation chromatography ... The report provides a basic overview of the industry ...
(Date:8/22/2014)... Toronto, Canada (PRWEB) August 22, 2014 ... traits in model organisms can be accelerated by ... design and manufacturing technologies, the custom SeqCap EZ ... such research. , Mr. Watson will additionally present ... seen with commercially available human and mouse exome ...
(Date:8/21/2014)... Finnish-Swedish research group at the Institute for Molecular ... institutet, Stockholm, has developed a novel "man and ... This innovative diagnostic aid was described in ... The method is based on computer vision algorithms ... combined with visualization of only the diagnostically most ...
(Date:8/21/2014)... IA (PRWEB) August 21, 2014 His ... LIBERTY Opening , The Court of His Majesty Willem-Alexander, ... will attend the Grand Opening of POET-DSM Advanced Biofuels’ ... Wednesday, Sept. 3. , The King will take part ... opening activity, scheduled for 11 a.m.-12:20 p.m. and tour ...
Breaking Biology Technology:Global and China Gel Permeation Chromatography (GPC) Industry Report 2014 2Efficient Identification of Protein-Coding Variants in a Model Organism Through Exome Sequencing, New Webinar Hosted by Xtalks 2A novel 'man and machine' decision support system makes malaria diagnostics more effective 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3
... ... ... ... ...
... ... ... ... ...
... ... ... ... ...
Cached Biology Technology:Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast 2Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast 3Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study 2Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study 3Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study 4Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 2WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 3WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 6WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 7WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 8WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 9WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 10WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 11WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 12WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 13WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 14WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 16WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 17WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 18WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 19WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 20WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 21WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 22WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 23WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 24WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 25WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 26WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 27WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 28WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 29
(Date:8/21/2014)... significant reduction in smog-producing toxins in past decade, ... new study shows that while the Greater Toronto ... toxins that contribute to smog, the city continues ... pollution., Smog, which can cause or aggravate health ... is produced by a set of complex photochemical ...
(Date:8/21/2014)... and other itchy, flaky maladies in humans has now ... reefs and the extreme environments of arctic soils and ... journal PLOS Pathogens considers the diversity, ecology, ... Malassezia in light of new insights gained from ... University of Hawai,i at Mānoa scientist Anthony Amend discovered ...
(Date:8/21/2014)... the Fram Strait is a key region in the global ... Greenland and Svalbard warm Atlantic water flows to the north ... Arctic water masses and sea ice push their way out ... of the Atlantic water cools here on its way to ... the water caused in this manner drives the global band ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3
... is available in German . , They ... species can still be found all over the world: mosses, ... Chemical Ecology in Jena, Germany, have now found out that ... volatiles when they are attacked − unlike many of the ...
... of Science Education and Technology G. Michael Barnett has ... by the Carnegie Foundation for the Advancement of Teaching ... (CASE) in recognition of his teaching excellence and positive ... is the only national program that recognizes excellence in ...
... viruses are particularly adept at defeating antiviral drugs because ... With at least one error in every genome they ... creating resistant mutants as they multiply. In the best-known ... to corner HIV and narrow its escape route. ...
Cached Biology News:Herbivore defense in ferns 2Herbivore defense in ferns 3Michael Barnett of Boston College named Professor of the Year for Massachusetts 2More than a machine 2
... Precision-designed for Optimal Microdissection , CapSure HS ... precise and rapid extraction of populations of ... samples with Laser Capture Microdissection., Ensure ... Molecular Analysis , All CapSure LCM Caps ...
... Microdissection , CapSure HS and CapSure Macro ... extraction of populations of pure cells from ... Capture Microdissection., Ensure the Integrity of ... All CapSure LCM Caps have a patented ...
... Precision-designed for Optimal Microdissection , CapSure ... the precise and rapid extraction of populations ... cytology samples with Laser Capture Microdissection., ... Downstream Molecular Analysis , All CapSure LCM ...
... Microdissection , CapSure HS and CapSure Macro ... extraction of populations of pure cells from ... Capture Microdissection., Ensure the Integrity of ... All CapSure LCM Caps have a patented ...
Biology Products: